Tag

AxoGen

CEO of UF Startup AxoGen is appointed to EyePoint Pharmaceuticals Board of Directors

EyePoint Pharmaceuticals, Inc., a pharmaceutical company committed to developing and commercializing therapeutics to improve the lives of patients with serious eye disorders, today announced the appointment of Karen Zaderej to its Board of Directors. Ms. Zaderej is currently the President, Chief Executive Officer and Chair of the Board at UF Startup and Accelerate graduate AxoGen, Inc., and brings more than 35 years of biopharmaceutical and medical device experience to the role.

Axogen RECON(SM) Clinical Study Completes Subject Follow-Up

UF startup and UF Innovate | Sid Martin Biotech graduate Axogen, a global leader in developing and marketing innovative surgical solutions for damage or discontinuity to peripheral nerves, announced that the RECON Clinical Study supporting its Biologics License Application (BLA) for Avance Nerve Graft has completed follow-up of study subjects.

Axogen’s Aim: Growing Tampa Into a Hub for Nerve Repair Treatment Technology

As a biotech company at the forefront of nerve repair treatment, UF startup and UF Innovate | Sid Martin Biotech alum Axogen, Inc., a global leader in developing and marketing innovative surgical solutions for damage or discontinuity to peripheral nerves, has always been near the front of the scientific curve.

Axogen, Inc. Appoints John H. Johnson to Board of Directors

UF startup and UF Innovate | Sid Martin Biotech alum Axogen, Inc., a global leader in developing and marketing innovative surgical solutions for damage or discontinuity to peripheral nerves, announced that John H. Johnson has been appointed to its Board of Directors.

Revolutionizing the Science of Nerve Repair and Regeneration

Peripheral nerve damage is estimated to affect more than 20 million people in the United States, causing symptoms that range from mild discomfort to severe disability. Damage is often undiagnosed or untreated, and the current standard of care procedures can be associated with limitations that impact the quality of life. UF startup and UF Innovate | Sid Martin Biotech alum Axogen, Inc., a company focused on the science, development, and commercialization of technologies for peripheral nerve regeneration and repair, aims to address these issues and provide more efficient treatment options to patients.
X